These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30226692)

  • 1. Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices.
    Lam VC; Hadley EE; Berenson AB; Hirth JM; Jennings K; Patel PR
    J Reprod Med; 2016; 61(11-12):529-33. PubMed ID: 30226692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satisfaction, early removal, and side effects associated with long-acting reversible contraception.
    Dickerson LM; Diaz VA; Jordon J; Davis E; Chirina S; Goddard JA; Carr KB; Carek PJ
    Fam Med; 2013; 45(10):701-7. PubMed ID: 24347187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.
    Secura GM; Allsworth JE; Madden T; Mullersman JL; Peipert JF
    Am J Obstet Gynecol; 2010 Aug; 203(2):115.e1-7. PubMed ID: 20541171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project.
    Allsworth JE; Secura GM; Ajibade OO; Peipert JF
    J Womens Health (Larchmt); 2018 May; 27(5):599-606. PubMed ID: 29768114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuation and satisfaction of reversible contraception.
    Peipert JF; Zhao Q; Allsworth JE; Petrosky E; Madden T; Eisenberg D; Secura G
    Obstet Gynecol; 2011 May; 117(5):1105-1113. PubMed ID: 21508749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
    Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
    J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in long-acting reversible contraception use among U.S. women aged 15-44.
    Branum AM; Jones J
    NCHS Data Brief; 2015 Feb; (188):1-8. PubMed ID: 25714042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C; Dude A; Haider S
    Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends of Contraceptive Choices Among Young Women in Inner City Houston.
    Patel PR; Abacan A; Smith PB
    J Pediatr Adolesc Gynecol; 2019 Oct; 32(5):487-490. PubMed ID: 31125608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Providing Long-Acting Reversible Contraception in an Academic Family Medicine Center.
    Amico J; Wu J
    Fam Med; 2015 Oct; 47(9):727-31. PubMed ID: 26473567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of women in the United States who use long-acting reversible contraceptive methods.
    Kavanaugh ML; Jerman J; Hubacher D; Kost K; Finer LB
    Obstet Gynecol; 2011 Jun; 117(6):1349-1357. PubMed ID: 21606745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.